Please Note:
This profile was automatically generated using 1 reference found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 1 reference found on the Internet. This information has not been verified. Learn more...
Web References
-
1. Biolog Technologies
www.Biolog-Tech.com/team.htm - [Cached]Published on: 12/7/2004 Last Visited: 2/10/2006
Dr. Doron Chema CEO is the founder of BioLog Technologies, combining top academic credentials with hands on market experience. He has served in the past as a Molecular Modeler in Prochon Biotech, Manager of the Software Development in the Yield Analysis Group, at Intel, Jerusalem, and a Software Developer in Amdocs. Dr. Chema holds a patent on Heterocyclic compounds as inhibitors of abnormal protein tyrosine kinase activity, and has published numerous papers in his field.
Dr. Chema holds a Ph.D. from the Hebrew ( Jerusalem ) and Tel Aviv Universities, in the field of developing novel methods for conformational analysis. He holds an M.Sc. from the Pharmacology School, The Hebrew University of Jerusalem and a B.Sc. in Chemistry and Biology from The Hebrew University of Jerusalem.
